Roivant Sciences Ltd banner

Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 20.3 EUR 12.28% Market Closed
Market Cap: €15B

Wall Street
Price Targets

87S Price Targets Summary
Roivant Sciences Ltd

Wall Street analysts forecast 87S stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 87S is 22.48 EUR with a low forecast of 18.32 EUR and a high forecast of 28.57 EUR.

Lowest
Price Target
18.32 EUR
10% Downside
Average
Price Target
22.48 EUR
11% Upside
Highest
Price Target
28.57 EUR
41% Upside
Roivant Sciences Ltd Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
146% Upside
NYXH
Nyxoah SA
147% Upside
ESQ
Esquire Financial Holdings Inc
7% Upside

Revenue
Forecast

5% / Year
Past Growth
227% / Year
Estimated Growth
Estimates Accuracy
-39%
Average Miss
5% / Year
Past Growth
227% / Year
Estimated Growth
Estimates Accuracy
-39%
Average Miss

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 227%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 87S's stock price target?
Price Target
22.48 EUR

According to Wall Street analysts, the average 1-year price target for 87S is 22.48 EUR with a low forecast of 18.32 EUR and a high forecast of 28.57 EUR.

What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
227%

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 227%.

Back to Top